Industrial preparation of heterocyclic modulator for lipid synthesis
The preparation of the selective fatty acid synthetase inhibitor SGL1 through a multi-step reaction process solves the problems of low impurities generation and yields during the preparation process in the prior art, and realizes efficient and low impurities industrial preparation to meet the needs of industrial applications.
Patent Information
- Application Number
- PCT/CN2024/097023
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-05
- Filing Date
- 2024-06-03
- Publication Date
- 2024-12-12
AI Technical Summary
It is difficult to effectively industrialize the preparation of SGL1 compounds, a powerful and safe selective fatty acid synthase inhibitor, in the prior art, and there are problems of impurities generation and low yields during the preparation process.
A multi-step reaction process is adopted, including the hydrolysis reaction of compound SGL1-SM1 under alkaline conditions to generate compound SGL1-A, and then react with dimethylaminoacetaldehyde dimethanol and hydrazine acetate to generate compound SGL1-B, and then in alkaline Hydrolysis reaction was carried out under conditions to produce compound SGL1-C, and finally reacted with compound SGL1-SM2 to produce target compound SGL1. The yield and purity were improved by controlling the reaction conditions and adding auxiliary agents.
It improves the yield of compound SGL1 and reduces impurities production. It is suitable for industrial applications. The yield reaches more than 85%, and the impurity content is low, meeting the requirements of industrial production.
Smart Images

Figure PCTCN2024097023-FTAPPB-I100001 
Figure PCTCN2024097023-FTAPPB-I100002 
Figure PCTCN2024097023-FTAPPB-I100003
Abstract
Description
Industrial preparation of heterocyclic regulators of lipid synthesis
[0001] Citation of Related Applications
[0002] This disclosure claims all rights and interests in the invention patent application with application number 202310658687.7, filed with the State Intellectual Property Office of the People's Republic of China on June 5, 2023, entitled "Industrial Preparation of Heterocyclic Regulators of Lipid Synthesis", and incorporates the entire contents thereof into this disclosure by reference.
[0003] field
[0004] The present disclosure relates generally to the field of medicinal chemistry, and more particularly to the field of pharmaceutical synthesis.
[0005] background
[0006] SGL1 compound, also known as ASC40 (codenamed TVB-2640 abroad), is a potent and safe selective oral small molecule inhibitor of fatty acid synthase. Its chemical name is 4-(1-(4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)piperidin-4-yl)benzonitrile, and its molecular formula is C 27 H 31 N5O2, the structural formula is as follows:
[0007] Overview
[0008] In one aspect, the present disclosure relates to a method for preparing compound SGL1-A, comprising: subjecting compound SGL1-SM1 to a hydrolysis reaction under alkaline conditions, wherein an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction.
[0009] In another aspect, the present disclosure relates to a method for preparing compound SGL1-B, comprising reacting compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.
[0010] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1-C, comprising: subjecting compound SGL1-B to a hydrolysis reaction under alkaline conditions.
[0011] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising reacting compound SGL1-C with compound SGL1-SM2.
[0012] On the other hand, the present disclosure relates to a method for preparing compound SGL1, which includes: the method for preparing compound SGL1-A described in the present disclosure; and / or the method for preparing compound SGL1-B described in the present disclosure; and / or the method for preparing compound SGL1-C described in the present disclosure; and / or the method for preparing compound SGL1 described in the present disclosure.
[0013] On the other hand, the present disclosure relates to a method for preparing compound SGL1, which includes: subjecting compound SGL1-SM1 to a hydrolysis reaction under alkaline conditions to obtain compound SGL1-A; reacting compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate to obtain compound SGL1-B; subjecting compound SGL1-B to a hydrolysis reaction under alkaline conditions to obtain compound SGL1-C; and reacting compound SGL1-C with compound SGL1-SM2 to obtain compound SGL1.
[0014] Details
[0015] In the following description, certain specific details are included to provide a comprehensive understanding of each disclosed embodiment. However, one skilled in the relevant art will recognize that the embodiments can still be implemented without one or more of these specific details and with other methods, components, materials, etc.
[0016] Unless otherwise required in this application, throughout the specification and the appended claims, the words "including," "comprising," "containing," and "having" should be interpreted in an open, inclusive sense, that is, "including but not limited to."
[0017] As used in this disclosure and the appended claims, singular references without indications of quantity include plural references unless the context clearly dictates otherwise.
[0018] Reference throughout this specification to "one embodiment," "an embodiment," "in another embodiment," or "in certain embodiments" means that at least one embodiment includes the specific referenced elements, structures, or features described in connection with that embodiment. Thus, appearances of the phrases "in one embodiment," "in an embodiment," "in another embodiment," or "in certain embodiments" in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the specific elements, structures, or features may be combined in any suitable manner in one or more embodiments.
[0019] It should be understood that the singular article "a," "an," and "the" used in the specification of the present disclosure and the appended claims includes plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "adding an acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate" includes "adding an acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate," or "adding two or more acids to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate."
[0020] definition
[0021] Accordingly, unless otherwise indicated to the contrary, the following terms used in the specification and appended claims shall have the following meanings:
[0022] In the present disclosure, the term "compound SGL1-A" refers to 5-carbamoyl-4-cyclobutyl-2-methylbenzoic acid, which has the following structure:
[0023] In the present disclosure, the term "compound SGL1-B" refers to methyl 4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoate hydrochloride, which has the following structure:
[0024] In the present disclosure, the term "compound SGL1-C" refers to 4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoic acid, which has the following structure:
[0025] In the present disclosure, the term "compound SGL1-SM1" refers to 5-cyano-4-cyclobutyl-2-methylbenzoic acid, which has the following structure:
[0026] In the present disclosure, the term "compound SGL1-SM2" refers to 4-(piperidin-4-yl)benzonitrile, which has the following structure:
[0027] In the present disclosure, the term "compound SGL1" refers to 4-(1-(4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)piperidin-4-yl)benzonitrile, which has the following structure:
[0028] In this disclosure, the term "equivalent" refers to the mass ratio of substances when they interact with each other, and is calculated based on the specific reactants specified.
[0029] In the present disclosure, the term "condensation agent" refers to a reaction auxiliary agent added in the condensation reaction. Specific implementation plan
[0030] In one aspect, the present disclosure relates to a method for preparing compound SGL1-A, comprising: subjecting compound SGL1-SM1 to a hydrolysis reaction under alkaline conditions, wherein an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction.
[0031] In certain embodiments, the concentration of the aqueous solution of hydrogen peroxide that can be used in the present disclosure is about 20 to 70% by mass.
[0032] In certain embodiments, the amount of the aqueous solution of hydrogen peroxide that can be used in the present disclosure added is about 7 to 15 equivalents based on compound SGL1-SM1.
[0033] In certain embodiments, the hydrolysis reaction is carried out at about 20 to 30°C.
[0034] In certain embodiments, the hydrolysis reaction is carried out for about 5 to 10 hours.
[0035] In certain embodiments, illustrative examples of basic conditions that can be used in the disclosed method for preparing compound SGL1-A include, but are not limited to, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, cesium carbonate, sodium carbonate, or any mixture thereof.
[0036] In certain embodiments, hydrogen peroxide can oxidize the easily oxidized cyanide group to a more stable thiocyanate ion (SCN). - ), thereby preventing the cyano group from being hydrolyzed into acid, thereby inhibiting the generation of by-products and improving the yield.
[0037] In certain embodiments, the 10 Kg scale-up yield of the method for preparing compound SGL1-A disclosed herein can reach over 90%.
[0038] In another aspect, the present disclosure relates to a method for preparing compound SGL1-B, comprising reacting compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.
[0039] In certain embodiments, the amount of dimethylaminoacetaldehyde dimethyl acetal added is about 3.0 to 6.0 equivalents based on compound SGL1-A.
[0040] In certain embodiments, hydrazine acetate is added in an amount of about 1.5 to 3.0 equivalents based on compound SGL1-A.
[0041] In certain embodiments, the reaction is carried out at about 60 to 70 °C.
[0042] In certain embodiments, the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate is purified using an organic solvent.
[0043] In certain embodiments, illustrative examples of organic solvents that can be used to purify the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate include, but are not limited to, methanol, ethanol, isopropanol, methyl tert-butyl ether, n-heptane, isopropyl acetate, acetone, methyl isobutyl ketone, isobutyl acetate, ethyl acetate, or any mixture thereof.
[0044] In certain embodiments, the method for preparing compound SGL1-B further comprises purifying the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate using ethyl acetate.
[0045] In certain embodiments, the method of preparing compound SGL1-B further comprises adding an acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.
[0046] In certain embodiments, illustrative examples of acids that can be used in the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate include, but are not limited to, formic acid, acetic acid, phosphoric acid, hydrochloric acid, maleic acid, fumaric acid, or any mixture thereof.
[0047] In certain embodiments, the method of preparing compound SGL1-B further comprises adding acetic acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.
[0048] In certain embodiments, the amount of acid added to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate is about 4 to 12 equivalents.
[0049] In certain embodiments, in the method for preparing compound SGL1-B, dimethylaminoacetaldehyde dimethyl acetal (DMA-DMA) is reacted with hydrazine acetate in a one-pot reaction to efficiently configure a 5-membered heterocycle.
[0050] In certain embodiments, the method for preparing compound SGL1-B disclosed herein can achieve a 10 kg scale-up yield of more than 70%.
[0051] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1-C, comprising: subjecting compound SGL1-B to a hydrolysis reaction under alkaline conditions.
[0052] In certain embodiments, the base is added in an amount of about 3 to 10 equivalents based on compound SGL1-B.
[0053] In certain embodiments, illustrative examples of basic conditions that can be used in the disclosed method for preparing compound SGL1-C include, but are not limited to, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, cesium carbonate, sodium carbonate, or any mixture thereof.
[0054] In certain embodiments, compound SGL1-B is hydrolyzed in the presence of sodium hydroxide.
[0055] In certain embodiments, the hydrolysis reaction is carried out at about 20 to 30°C.
[0056] In certain embodiments, the hydrolysis reaction is carried out for about 3 to 20 hours.
[0057] In certain embodiments, the method for preparing compound SGL1-C disclosed herein achieves 10 Kg-scale scale-up with a yield greater than 70%.
[0058] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising reacting compound SGL1-C with compound SGL1-SM2.
[0059] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out in the presence of a condensing agent.
[0060] In certain embodiments, illustrative examples of condensing agents that can be used in the reaction of compound SGL1-C with compound SGL1-SM2 include, but are not limited to, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU), dicyclohexylcarbodiimide (DCC), N,N'-diisopropylcarbodiimide (DIC), 1-hydroxybenzotriazole (HOBT), propylphosphonic anhydride (T3P), n-butylphosphonic anhydride (T4P), or any mixture thereof.
[0061] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out in the presence of n-butylphosphoric anhydride (T4P).
[0062] In certain embodiments, in the reaction of compound SGL1-C with compound SGL1-SM2, n-butylphosphonic anhydride (T4P) is added in an amount of at least about 1.5 equivalents based on compound SGL1-C.
[0063] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out under basic conditions.
[0064] In certain embodiments, the base is added in an amount of at least 5 equivalents based on compound SGL1-C.
[0065] In certain embodiments, illustrative examples of basic conditions that can be used in the method for preparing compound SGL1 of the present disclosure include, but are not limited to, N,N-diisopropylethylamine (DIEA), triethylamine (TEA), pyridine (Py), 4-dimethylaminopyridine (DMAP), 2,6-lutidine, N-methylmorpholine (NMM), potassium carbonate, sodium carbonate, or any mixture thereof.
[0066] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out in the presence of diisopropylethylamine (DIEA).
[0067] In certain embodiments, the amount of compound SGL1-SM2 added is about 1.05 to 5 equivalents based on compound SGL1-C.
[0068] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out at 20 to 30 °C.
[0069] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out for about 5 to 20 hours.
[0070] In certain embodiments, the method for preparing compound SGL1 disclosed herein performs dehydration condensation in the presence of n-butylphosphoric anhydride (T4P), efficiently completing the preparation of amide with a yield of over 85%.
[0071] In another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising:
[0072] The method for preparing compound SGL1-A described herein; and / or
[0073] The method for preparing compound SGL1-B described in the present disclosure; and / or
[0074] The method for preparing compound SGL1-C described in the present disclosure; and / or
[0075] The present disclosure provides a method for preparing compound SGL1.
[0076] In another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising:
[0077] The compound SGL1-SM1 is hydrolyzed under alkaline conditions to obtain compound SGL1-A;
[0078] The compound SGL1-A is reacted with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate to obtain a compound SGL1-B;
[0079] hydrolyzing the compound SGL1-B under alkaline conditions to obtain compound SGL1-C; and
[0080] The compound SGL1-C is reacted with the compound SGL1-SM2 to obtain the compound SGL1.
[0081] In certain embodiments, the disclosed method for preparing heterocyclic modulators of lipid synthesis can improve yield, reduce impurities, and is suitable for industrial applications.
[0082] Hereinafter, the present disclosure will be explained in detail through the following examples in order to better understand the various aspects and advantages of the present application. However, it should be understood that the following examples are non-limiting and are only used to illustrate certain embodiments of the present disclosure.
[0083] Example
[0084] The reagents and equipment used in the examples of this disclosure are conventional and commercially available. For example:
[0085] Example 1
[0086] Preparation of compound SGL1-A
[0087] Add purified water (6.03 equivalents, 66.33 kg) to the reactor. Stirring was initiated, followed by the addition of anhydrous ethanol (2.38 equivalents, 26.18 kg) and sodium hydroxide (0.56 equivalents, 6.16 kg). After stirring, SGL1-SM1 (1 equivalent, 11 kg) was added. The reactor was rinsed with purified water (1.05 equivalents, 11.55 kg). A 30% hydrogen peroxide solution (3.73 equivalents, 41.03 kg) was slowly added dropwise. After stirring at 25±5°C for 5 hours, a sample was collected and tested for IPC-1 by HPLC. The sample was tested until the reaction was satisfactory. A 20% sodium bisulfite solution (2.9 equivalents, 31.9 kg) in water (11.5 equivalents, 126.5 kg) was pre-prepared. Once the solution was satisfactory, 20% sodium bisulfite solution was added dropwise to the reactor and stirred at 25±10°C for 1 hour. Add hydrochloric acid to adjust the pH to 1 to 2, control the temperature at 25±10°C and stir for 2 hours, filter, and rinse the filter cake with purified water (3.04 equivalents, 33.44 kg) to obtain a crude wet product of SGL1-A. Purified water (19.04 equivalents, 209.44 kg) was added to the reactor, stirring was initiated, and crude SGL1-A wet product was added. The reactor walls were washed with purified water (1.00 equivalents, 11 kg). The reaction mixture was heated to 35±5°C and maintained for at least 1 hour. The reaction mixture was then cooled to 20±5°C and centrifuged. The filter cake was rinsed twice with purified water (3.0 equivalents, 33 kg) to obtain refined wet SGL1-A. The wet product was sampled and sent to IPC-2 for analysis. The refined wet SGL1-A product was transferred to a vacuum dryer with the jacket temperature maintained at 55±5°C for 15 hours. A sample was taken from IPC-3 for KF and LOD testing (KF ≤ 0.5%, LOD ≤ 2.0%). Once qualified, the mixture was cooled and powdered to obtain 11.09 kg of dry SGL1-A, with a yield of 93.0%.
[0088] 1 H NMR (500MHz, DMSO-d6) δ12.37(s,1H),7.72(s,1H),7.28(d,J=7.8Hz,1H),7.70(d ,J=7.8Hz,1H),7.22(s,1H),3.11(q,J=5.3Hz,1H),2.45(s,3H),1.97-1.64(m,7H)
[0089] The above Example 1 was repeated using the following process parameters, and the results are shown in Table 1.
[0090] Table 1
[0091] Example 2
[0092] Preparation of compound SGL1-B
[0093] Under nitrogen, add tetrahydrofuran (6.27 equivalents, 68.97 kg) to the reactor and start stirring. Add dimethylaminoacetaldehyde dimethyl acetal (DMA-DMA) (1.7173 equivalents, 18.8903 kg) to the reactor. Add SGL1-A (1.0 equivalents, 11 kg) to the reactor. After the addition is complete, wash the reactor walls with tetrahydrofuran (0.903 equivalents, 9.933 kg). Raise the system temperature to 65±5°C, maintain stirring for 5 hours, then remove an IPC-1 sample for testing. The sample passed the central control. Adjust the reactor temperature to 30±10°C. Add hydrazine acetate (0.596 equivalents, 6.556 kg) into the kettle, and then add acetic acid (1.0724 equivalents, 11.7964 kg) dropwise. After the addition is complete, continue to stir and keep warm at 30±10°C for 30 minutes, then raise the temperature to 50±5°C, stir and keep warm for 2 hours, and then take the IPC-2 sample for testing.
[0094] After the reaction is complete, cool to 30±10°C. Add purified water (7.245 equivalents, 79.695 kg) to the reactor and concentrate under reduced pressure to 7 times the volume while maintaining the temperature at ≤50°C. Cool to 20±5°C, stir for 1 hour, and then centrifuge and filter. Wash the filter cake with purified water (2.092 equivalents, 23.012 kg) to obtain free SGL1-B. Transfer the wet product to a vacuum dryer with the jacket temperature controlled at 45 to 55°C for at least 10 hours. Take an IPC-3 sample and test the KF until the KF is ≤2% to obtain the dry product of free SGL1-B. Under nitrogen protection, ethyl acetate (8.265 equivalents, 90.915 kg) was added to the reactor and stirring was started; free dry product of SGL1-B was added. After the addition was completed, the reactor wall was washed with ethyl acetate (0.878 equivalents, 9.658 kg), stirred for 10 minutes, heated to 60±5°C, kept warm and stirred for 1 hour, then cooled to 25±5°C, the reactor temperature was controlled at 20±10°C, hydrochloric acid (0.51 equivalents, 5.61 kg) was added dropwise, and kept warm and stirred at this temperature for 1 hour. The mixture was centrifuged and the filter cake was washed with ethyl acetate (3.571 equivalents, 39.28 kg) to obtain wet product SGL1-B; the wet product SGL1-B was transferred to a vacuum dryer, the jacket temperature was controlled at 45 to 55°C, and dried for at least 10 hours. An IPC-5 sample was taken to detect the LOD, until the LOD was ≤2%. After passing the test, the dry product SGL1-B was obtained, 10.87 kg, with a yield of 71.6%.
[0095] 1H NMR (500MHz, DMSO-d6) δ11.05(s,2H),8.49(s,2H),7.34(s,2H),3.88(s,6H),3.29(dd,J=5.6,4.9Hz,2H),2.78(s, 6H),2.50(s,6H),1.96-1.87(m,4H),1.87-1.81(m,1H),1.81-1.76(m,5H),1.75(d,J=1.7Hz,1H),1.74-1.64(m,2H)
[0096] The above Example 2 was repeated using the following process parameters, and the results are shown in Table 2.
[0097] Table 2
[0098] Example 3
[0099] Preparation of compound SGL1-C
[0100] Under nitrogen, methanol (3.58 equivalents, 38.66 kg) was added to the reactor. Stirring was initiated, followed by purified water (1.53 equivalents, 16.52 kg). The reactor temperature was maintained below 50°C. Sodium hydroxide (0.369 equivalents, 3.99 kg) was added and stirred for at least 30 minutes. SGL1-B (1.0 equivalents, 10.80 kg) was then added. After the additions were complete, the reactor walls were washed with methanol (0.82 equivalents, 8.86 kg). The system temperature was then raised to 60±5°C, stirred at this temperature for 3 hours, and an IPC-1 sample was collected for testing. The SGL1-B content was required to be ≤0.5%. After passing the test, the reactor temperature was lowered to 40±5°C, purified water (4.77 equivalents, 51.52 kg) was added, and the mixture was concentrated under reduced pressure to 6 times its volume. The temperature in the autoclave was lowered to 20±10°C. Hydrochloric acid was added dropwise at this temperature to adjust the pH to 1 to 3. The mixture was stirred at this temperature for 1 hour. The mixture was centrifuged and the filter cake was rinsed with purified water (5.0 equivalents, 54 kg) to obtain wet product SGL1-C. The qualified wet product was transferred to a vacuum dryer with the jacket temperature controlled at 40 to 55°C for at least 10 hours. An IPC-3 sample was taken for KF testing until the KF was ≤ 0.5%. The dry product SGL1-C was obtained, weighing 8.79 kg and yielding 96.6%.
[0101] 1H NMR (500MHz, DMSO-d6) δ12.06(s,1H),10.98(s,1H),8.21(s,1H),7.27(s,1H),3.34(dd,J=5.6,4.9Hz,1H),2.43(d,J =16.1Hz,6H),1.98-1.87(m,3H),1.84(dd,J=7.6,5.3Hz,1H),1.84-1.78(m,2H),1.81-1.71(m,1H),1.74-1.66(m,1H)
[0102] The above Example 3 was repeated using the following process parameters. The results are shown in Table 3.
[0103] Table 3
[0104] Example 4
[0105] Preparation of compound SGL1
[0106] Under nitrogen, add dichloromethane (6.88 equivalents, 60.54 kg) to the reactor and start stirring. Add SGL1-C (1.0 equivalents, 8.8 kg) and SGL1-SM2 (0.86 equivalents, 7.6 kg) to the reactor. After the additions are complete, wash the reactor walls with dichloromethane (1.34 equivalents, 11.79 kg). Adjust the reactor temperature to 15±5°C and dropwise add N,N-diisopropylethylamine (2.36 equivalents, 20.77 kg) and butylphosphonic anhydride 50% ethyl acetate solution (4 equivalents, 35.2 kg). After the additions are complete, allow the reaction to react at room temperature for 2 hours before submitting the sample for IPC-1 testing. SGL1-C should be ≤2%. After passing the test, ethyl acetate (9.03 equivalents, 79.46 kg) was added to the autoclave. The mixture was concentrated to 15 times its volume under reduced pressure at 40°C. Purified water (5.06 equivalents, 44.53 kg) was added, stirred for 2 hours, and centrifuged. The filter cake was washed with purified water (1.99 equivalents, 17.51 kg) to obtain SGL1 wet product 1. Anhydrous ethanol (2.73 equivalents, 24.02 kg) was added to the autoclave, stirring was initiated, and SGL1 wet product 1 was added. The autoclave temperature was raised to 78±5°C. At this temperature, the mixture passed through a precision filter into the clean area. Purified water (1.74 equivalents, 15.31 kg) was added dropwise after filtration, and stirring was continued at this temperature for at least 0.5 hour. The system temperature was lowered to 15±10°C over 6 hours, and the mixture was kept at this temperature with stirring for 6 hours. After centrifugation, the filter cake was washed with a 1:1 mixture of ethanol (0.47 equivalents, 4.14 kg) and purified water (0.47 equivalents, 4.14 kg) to obtain a refined wet product of SGL1. An IPC-2 sample was taken for testing. The refined wet product of SGL1 was dried under reduced pressure at 40 to 55°C for 10 hours. An IPC-3 sample was taken for GC testing of the residual solvent until it met the standard. This yielded 13.085 kg of SGL1 with a yield of 88.1%.
[0107] 1 HNMR(400MHz,DMSO-d6)δ13.66(s,1H),7.75(d,J=8.0Hz, 2H),7.55(s,1H),7.47(d,J=8.0Hz,2H),7.37(s,1H),4.72(d,J=12.5Hz,1H),4.31(s,1H),3.44(m,1H),3.13(t,J=12.0Hz,1H),2.9 0-2.85(m,2H),2.39(s,3H),2.36-2.26(m,3H),2.17(s,2H),2.07-2.00(m,2H),1.89-1.71(m,3H),1.67-1.64(m,2H),1.46(s,1H).
[0108] The above Example 4 was repeated using the following process parameters, and the results are shown in Table 4.
[0109] Table 4
[0110] In this disclosure, relational terms such as first and second, etc. are used merely to distinguish one entity or operation from another entity or operation, but do not necessarily require or imply any actual relationship or order between these entities or operations.
[0111] It will be appreciated from the foregoing that, although specific embodiments of the present disclosure have been described for illustrative purposes, various modifications or variations may be made by those skilled in the art without departing from the spirit and scope of the present disclosure. Such modifications or variations are intended to fall within the scope of the appended claims of the present disclosure.
Claims
1. A method for preparing compound SGL1-A, comprising: The compound SGL1-SM1 is subjected to a hydrolysis reaction under alkaline conditions, wherein an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction.
2. The method of claim 1, wherein: The amount of the aqueous solution of hydrogen peroxide added is 7 to 15 equivalents based on the compound SGL1-SM1.
3. The method of claim 1 or 2, wherein the hydrolysis reaction is carried out at 20 to 30°C.
4. A method for preparing compound SGL1-B, comprising: The compound SGL1-A is reacted with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.
5. The method of claim 4, wherein the amount of dimethylaminoacetaldehyde dimethyl acetal added is 3.0 to 6.0 equivalents based on the compound SGL1-A.
6. The method according to claim 4 or 5, wherein the amount of hydrazine acetate added is 1.5 to 3.0 equivalents based on the compound SGL1-A.
7. The process according to any one of claims 4 to 6, wherein the reaction is carried out at 60 to 70°C.
8. The method according to any one of claims 4 to 7, further comprising refining the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate using an organic solvent, preferably methanol, ethanol, isopropanol, methyl tert-butyl ether, n-heptane, isopropyl acetate, acetone, methyl isobutyl ketone, isobutyl acetate, ethyl acetate or any mixture thereof, more preferably ethyl acetate.
9. The method according to any one of claims 4 to 8, further comprising adding an acid, preferably formic acid, acetic acid, phosphoric acid, hydrochloric acid, maleic acid, fumaric acid or any mixture thereof, more preferably acetic acid, to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.
10. A method for preparing compound SGL1-C, comprising: The compound SGL1-B is subjected to a hydrolysis reaction under alkaline conditions.
11. The method of claim 10, wherein the base is added in an amount of 3 to 10 equivalents based on the compound SGL1-B.
12. The method of claim 10 or 11, wherein the alkaline condition is selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, cesium carbonate, sodium carbonate or any mixture thereof, preferably sodium hydroxide.
13. The process according to any one of claims 10 to 12, wherein the hydrolysis reaction is carried out at 20 to 30°C.
14. The method according to any one of claims 10 to 13, wherein the hydrolysis reaction is carried out for 3 to 20 hours.
15. A method for preparing compound SGL1, comprising: The compound SGL1-C is reacted with the compound SGL1-SM2.
16. The method of claim 15, wherein the reaction is carried out in the presence of a condensing agent, preferably the condensing agent is selected from 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU), dicyclohexylcarbodiimide (DCC), N,N'-diisopropylcarbodiimide (DIC), 1-hydroxybenzotriazole (HOBT), propyl phosphoric anhydride (T3P), n-butyl phosphoric anhydride (T4P) or any mixture thereof, more preferably n-butyl phosphoric anhydride (T4P), and even more preferably, the amount of n-butyl phosphoric anhydride (T4P) added is at least 1.5 equivalents based on the compound SGL1-C.
17. The method of claim 15 or 16, wherein the reaction is carried out under basic conditions, preferably the base is added in an amount of at least 5 equivalents based on the compound SGL1-C.
18. The method of claim 17, wherein the alkaline condition is selected from N,N-diisopropylethylamine (DIEA), triethylamine (TEA), pyridine (Py), 4-dimethylaminopyridine (DMAP), 2,6-lutidine, N-methylmorpholine (NMM), potassium carbonate, sodium carbonate or any mixture thereof, preferably diisopropylethylamine (DIEA).
19. A method for preparing compound SGL1, comprising: The method according to any one of claims 1 to 3; and / or The method of any one of claims 4 to 9; and / or The method of any one of claims 10 to 14; and / or A method as claimed in any one of claims 15 to 18.
20. A method for preparing compound SGL1, comprising: The compound SGL1-SM1 is subjected to a hydrolysis reaction under alkaline conditions to obtain a compound SGL1-A; The compound SGL1-A is reacted with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate to obtain a compound SGL1-B; The compound SGL1-B is subjected to a hydrolysis reaction under alkaline conditions to obtain a compound SGL1-C; as well as The compound SGL1-C is reacted with the compound SGL1-SM2 to obtain the compound SGL1.
Citation Information
Patent Citations
Industrial preparation of heterocyclic modulators of lipid synthesis
CN119080742A
Heterocyclic modulators of lipid synthesis
CN103561576A
Heterocyclic modulators of lipid synthesis
CN104507928A
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and / or IFN alpha responses
CN104884454A
Heterocyclic modulators of lipid synthesis and combinations thereof
CN106061963A
Cited By
Combination therapies of FASN inhibitors with thyroid hormone receptor agonists
US12746242B2
